A PYMNTS Company

International: Buyer announced for Nestle’s divested infant-nutrition licenses

By  |  April 18, 2013

Just days after it was announced that Nestle SA would agree to find a buyer for its licenses of infant formula as part of a deal to acquire Pfizer Inc., Aspen Pharmacare Holdings Ltd., based in South Africa, has struck a deal to buy the licenses that will allow the company to sell infant formula in Australia, South Africa and Namibia. Antitrust regulators in Australia have reportedly approved of the deal, while those in South Africa and Namibia are pending approval, according to Aspen. Aspen is the largest generic medicine producer in the Southern Hemisphere, supplying medicine to more than 150 countries. The move is part of a larger effort to expand businesses within Australia, Latin America and sub-Sahara Africa.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Live Mint

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.